Beyond WHO approval, EuBiologics targets global typhoid vaccine market
EuBiologics, the Korean vaccine maker known as the largest supplier of oral cholera vaccines to global health programs for less-developed countries, is lining up its recently approved typhoid conjugate vaccine for international procurement to target an initial UNICEF allocation in the latter half of
EuBiologics, the Korean vaccine maker known as the largest supplier of oral cholera vaccines to global health programs for less-developed countries, is lining up its recently approved typhoid conjugate vaccine for international procurement to target an initial UNICEF allocation in the latter half of
💬 留言板 — 歡迎分享你的想法！
登入 Google 帳號即可留言